Tyrosine kinase expression is increased in papillary thyroid carcinoma of children and young adults

被引:5
|
作者
Patel, A
Fenton, C
Ramirez, R
Dinauer, CA
Tuttle, RM
Nikiforov, YE
Francis, GL
机构
[1] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Pediat, Bethesda, MD 20814 USA
[2] Walter Reed Army Med Ctr, Dept Clin Invest, Washington, DC 20307 USA
[3] Walter Reed Army Med Ctr, Dept Pediat, Washington, DC 20307 USA
[4] Walter Reed Army Med Ctr, Dept Med, Washington, DC 20307 USA
[5] Univ Cincinnati, Coll Med, Dept Pathol, Cincinnati, OH USA
来源
关键词
tyrosine kinase; cancer; neoplasia; thyroid cancer; review;
D O I
10.2741/Patel
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tyrosine kinases (TKs) are important candidate genes for malignant transformation and at least 21 different TKs have been identified in the thyroid gland. We hypothesized that the collective activity of these TKs might be increased in thyroid carcinoma and have association with the clinical behavior of individual tumors. To test this, we determined TK expression by immunohistochemistry in 74 archival thyroid tissue blocks (48 papillary thyroid carcinoma, PTC; 9 follicular thyroid carcinoma, FTC; 17 benign thyroid diseases) from children and young adults. Mean TK expression was greater for PTC (2.1 +/- 0.11) than benign lesions (1.6 +/- 0.2, p = 0.027), and also tended to be greater in ETC (2.1 +/- 0.25, p = 0.12). Recurrence risk was three-fold greater for PTC with intense TK expression (4/15, 27%) than for PTC with minimal - moderate TK expression (3/33, 9.0%). However, this was not statistically significant (p = 0.10). In PTC, TK expression correlated with expression of the receptor for hepatocyte growth factor/scatter factor (cMET, r = 0.31, p = 0.044). In FTC, TK expression did not correlate with cMET, but tended to be greater in young patients (r= -0.59, p = 0.09). We conclude that TK expression is increased in PTC and possibly associated with an increased recurrence risk.
引用
收藏
页码:A1 / A9
页数:9
相关论文
共 50 条
  • [1] Increased Expression of GARP in Papillary Thyroid Carcinoma
    Zhang, Xiaoxu
    Guo, Miao
    Yang, Jing
    Zheng, Yuxiao
    Xiao, Yanjie
    Liu, Wei
    Ren, Fu
    ENDOCRINE PATHOLOGY, 2019, 30 (01) : 1 - 7
  • [2] Increased Expression of GARP in Papillary Thyroid Carcinoma
    Xiaoxu Zhang
    Miao Guo
    Jing Yang
    Yuxiao Zheng
    Yanjie Xiao
    Wei Liu
    Fu Ren
    Endocrine Pathology, 2019, 30 : 1 - 7
  • [3] The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults
    Fenton, CL
    Lukes, Y
    Nicholson, D
    Dinauer, CA
    Francis, GL
    Tuttle, RM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03): : 1170 - 1175
  • [4] PROTEIN TYROSINE KINASE-ACTIVITY IN HUMAN THYROID PAPILLARY CARCINOMA
    YASUDA, Y
    SAKANOUE, Y
    HATADA, T
    NAKAI, T
    UTSUNOMIYA, J
    ACTA ONCOLOGICA, 1992, 31 (04) : 409 - 412
  • [5] Increased expression of mRNA specific for thymidine kinase, deoxycytidine kinase or thymidine phosphorylase in human papillary thyroid carcinoma
    Karbownik, M
    Brzezianska, E
    Lewinski, A
    CANCER LETTERS, 2005, 225 (02) : 267 - 273
  • [6] OCCULT PAPILLARY CARCINOMA OF THE THYROID IN CHILDREN AND YOUNG-ADULTS - A SYSTEMIC AUTOPSY STUDY IN FINLAND
    FRANSSILA, KO
    HARACH, HR
    CANCER, 1986, 58 (03) : 715 - 719
  • [7] Management of Thyroid Carcinoma in Children and Young Adults
    Rapkin, Louis
    Pashankar, Farzana D.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2012, 34 : S39 - S46
  • [8] Increased Type 3 Deiodinase Expression in Papillary Thyroid Carcinoma
    Romitti, Marian
    Wajner, Simone Magagnin
    Zennig, Nadja
    Goemann, Iuri Martin
    Bueno, Ana Laura
    Meyer, Erika L. Souza
    Maia, Ana Luiza
    THYROID, 2012, 22 (09) : 897 - 904
  • [9] Response to Tyrosine Kinase Inhibitor Lenvatinib in a Child with Refractory Papillary Thyroid Carcinoma
    Mahajan, Priya
    Quintanilla, Norma
    Lopez, Monica
    Orth, Robert
    Athanassaki, Ioanna
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S78 - S78
  • [10] Expression of the Axl receptor tyrosine kinase in human thyroid carcinoma
    Ito, T
    Ito, M
    Naito, S
    Ohtsuru, A
    Nagayama, Y
    Kanematsu, T
    Yamashita, S
    Sekine, I
    THYROID, 1999, 9 (06) : 563 - 567